We are live on ! Find out more
TCM

Tributary Capital Management Portfolio holdings

AUM $1.22B
1-Year Est. Return 44.12%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+44.12%
3 Year Est. Return
+82.34%
5 Year Est. Return
+109.28%
10 Year Est. Return
+466.43%
AUM
$1.17B
AUM Growth
+$191M
Cap. Flow
+$63M
Cap. Flow %
5.38%
Top 10 Hldgs %
22.07%
Holding
211
New
15
Increased
74
Reduced
103
Closed
6

Top Buys

Rank Stock Value
1
UBSI icon
United Bankshares
UBSI
+$13.3M
2
HMSY
HMS Holdings Corp.
HMSY
+$9.37M
3
ENS icon
EnerSys
ENS
+$7.72M
4
AMN icon
AMN Healthcare
AMN
+$7.33M
5
SPSC icon
SPS Commerce
SPSC
+$6.63M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Industrials 17.71%
3 Financials 15.23%
4 Healthcare 11.45%
5 Consumer Discretionary 10.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLK icon
176
Blackrock
BLK
$175B
$479K 0.04%
880
-50
-5% -$25.2K
CSX icon
177
CSX Corp
CSX
$93.9B
$471K 0.04%
20,250
-750
-4% -$16.6K
HZNP
178
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$467K 0.04%
+8,400
New +$359K
TKR icon
179
Timken Company
TKR
$8.92B
$466K 0.04%
10,250
-400
-4% -$15.8K
DHI icon
180
D.R. Horton
DHI
$40.8B
$455K 0.04%
8,200
-9,200
-53% -$446K
PAYC icon
181
Paycom
PAYC
$10.1B
$449K 0.04%
1,450
-100
-6% -$26.6K
BSX icon
182
Boston Scientific
BSX
$71.4B
$448K 0.04%
12,750
+1,250
+11% +$45K
CB icon
183
Chubb
CB
$137B
$431K 0.04%
3,400
-150
-4% -$17.4K
EW icon
184
Edwards Lifesciences
EW
$51.5B
$422K 0.04%
6,100
-290
-5% -$20.6K
LW icon
185
Lamb Weston
LW
$7.16B
$421K 0.04%
6,580
-7,550
-53% -$456K
OSK icon
186
Oshkosh
OSK
$9.47B
$416K 0.04%
5,808
+29
+0.5% +$1.98K
NTRS icon
187
Northern Trust
NTRS
$33.7B
$411K 0.04%
5,175
-100
-2% -$7.93K
RTX icon
188
RTX Corp
RTX
$301B
$406K 0.03%
+6,587
New +$411K
BKNG icon
189
Booking.com
BKNG
$156B
$398K 0.03%
6,250
-250
-4% -$15.2K
CBRE icon
190
CBRE Group
CBRE
$42.7B
$398K 0.03%
8,800
-5,300
-38% -$229K
XOM icon
191
ExxonMobil
XOM
$642B
$398K 0.03%
8,900
-300
-3% -$13.5K
OMF icon
192
OneMain Financial
OMF
$7.48B
$393K 0.03%
16,000
+1,800
+13% +$41K
CME icon
193
CME Group
CME
$95B
$376K 0.03%
2,315
-115
-5% -$20.6K
BIIB icon
194
Biogen
BIIB
$30.5B
$368K 0.03%
1,375
-55
-4% -$16.5K
XRAY icon
195
Dentsply Sirona
XRAY
$2.64B
$348K 0.03%
7,900
-7,700
-49% -$326K
MLM icon
196
Martin Marietta Materials
MLM
$32.3B
$320K 0.03%
1,550
-1,510
-49% -$290K
SWX icon
197
Southwest Gas
SWX
$6.69B
$297K 0.03%
4,300
-100
-2% -$7.27K
USB icon
198
US Bancorp
USB
$99.4B
$265K 0.02%
7,200
-450
-6% -$16K
MTZ icon
199
MasTec
MTZ
$20.8B
$262K 0.02%
5,850
-9,400
-62% -$356K
WFC icon
200
Wells Fargo
WFC
$265B
$253K 0.02%
9,900
-200
-2% -$5.47K

Similar funds

Tributary Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Tributary Capital Management held 211 positions worth $1.17B, up 19% from $980M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tributary Capital Management deployed $63M of net new capital in Q2 2020, opening 15 new positions and adding to 74 existing holdings. Its largest new stake was HMS Holdings Corp.: 323,916 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Methode Electronics, an estimated $9.6M trimmed.

  • Tributary Capital Management's largest Q2 2020 buy was HMS Holdings Corp.: 323,916 shares worth $10.5M.
  • Tributary Capital Management added most to United Bankshares in Q2 2020, an estimated $13.3M increase.
  • Tributary Capital Management's biggest Q2 2020 reduction was Methode Electronics, cutting an estimated $9.6M.
  • Tributary Capital Management fully exited Great Western Bancorp, Inc. in Q2 2020, selling an estimated $10.5M.
  • Tributary Capital Management's ten largest holdings make up 22% of its $1.17B portfolio in Q2 2020.
  • Tributary Capital Management opened 15 new positions and closed 6 in Q2 2020.
  • Tributary Capital Management's portfolio value rose 19% quarter-over-quarter to $1.17B.

Based on Tributary Capital Management's 13F filing for Q2 2020, filed 20 Jul 2020.